NAT/Nucleic Acid Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--US, Europe, Japan--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

This unique seven-country report contains 1,398-page report and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade. 

Highlights

- Business and technological trends in seven major markets
- Five year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing innovative technologies
   and products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and  NAT
by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of major suppliers of NAT
reagent kits and components.

- Ten-year test volume and sales forecasts for major
applications, including:

- Infectious Diseases      - Forensic Testing
- Cancer                        - Paternity Testing/HLA Typing
- Genetic Diseases         - Others

- Ten-year test volume and sales projections for over 30
NAT assays.

- A comprehensive analysis of the sequencing market,
by country and laboratory segment, including:

- Industrial        - Academic
- Government   - Commercial

- Detailed market segmentation analysis, including
review of the market dynamics, trends, structure, size,
growth and major suppliers, by country.

Product/Technology Review

- Comparison of leading NAT
analyzers from Abbott, Beckman Coulter, BD, Bio-Rad,
Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of NAT technologies,
test formats, detection methodologies, trends
in testing automation and over 30 target/signal
amplification methods, including:

- PCR     - bDNA
- SDA     - NASBA
- TMA    - SSSR, and others
- LCR

- Worldwide listings of companies, universities and
research centers developing new NAT
technologies and products.

Competitive Assessments

- Extensive strategic assessments
of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing
tactics, collaborative arrangements and new technologies/products
in R&D.

- Comprehensive listings of companies developing and
marketing NAT products, by test and
application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities
with potentially significant market appeal during
the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the proprietary data base was conducted.

US NAT/Nucleic Acid Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

Highlights Comprehensive 1,157-page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and

USD 9500 View Report

UK NAT/Nucleic Acid Testing Analyzers and Reagents Market, 2019-2023: Supplier Shares and Sales Segment Forecasts by Product--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

Highlights Comprehensive 1,122-page market segmentation analysis of the UK NAT market. Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and

USD 6700 View Report

Europe Nucleic Acid Testing (NAT) Market, 2019-2023: France, Germany, Italy, Spain, UK--Market Share Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

This new 1,273-page comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market

USD 9500 View Report

Global Nucleic Acid Testing Instrument Market Report 2019, Competitive Landscape, Trends and Opportunities

The Nucleic Acid Testing Instrument market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated

USD 2950 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available